Inspiration And Expert Advice: Expert Columns
Daniel Trecroci's Columns
Diabetes ‘Power Couple’ Announces a Marriage of Technologies
Medtronic and Lifescan unite in latest monitoring gadget.
New Non-Injectable/Non-Inhalable Insulin Formulations in the Works
One product getting favorable reviews in clinical trial.
Oral Meds on the Horizon
DPP-4 Landscape Looks Good, But What About Other Drugs.
Will There Ever Be a Generic Insulin?
FDA approval still in the works.
Technology Conference Highlights the Future of Diabetes Care
Potential changes help patients and doctors alike.
You and Your Thyroid
Why every person with diabetes should get it examined.
Anticipating High and Low BGs with BGAT
Training program teaches inner detective skills.
Glycemic Variability
It's not just about the A1C any more.
With Oral Type 2 Meds, Newer Doesn’t Necessarily Mean Better
Effectiveness, cost makes older agents good contenders in treatment.
Avandia Story Heats Up
Will Doctors and Patients Pay A Price?
Waiting to Exhale - Part 2
Trials continue as new products press their way to market.
Will Exubera find new life as a Type 2 insulin?
Weight Loss at What Cost?
OTC drug comes with unflattering gastrointestinal side effects.